← All news
Markets

Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital

1 source ·1 article ·Aug 26, 17:02 UTC XOMA Royalty Ligand Pharmaceuticals

Covered by 1 outlet

All coverage · 1 article